5064
当前位置: 首页   >  成果及论文
成果及论文
  1. Gong L, Zhang Y, Liu C, Zhang M, Han S. Application of Radiosensitizers in Cancer Radiotherapy. Int J Nanomedicine. 2021;16:1083-1102. https://doi.org/10.2147/IJN.S290438

  2. Jia Z, Tu K, Xu Q, Gao W, Liu C, Fang B, Zhang M. A novel disease-associated nucleic acid sensing platform based on split DNA-scaffolded sliver nanocluster. Analytica Chimica Acta. 2021;1175: 338734  https://doi.org/10.1016/j.aca.2021.338734.

  3. Wang X, Zhang M, Woloshun RR, Yu Y, Lee JK, Flores SRL, Merlin D, Collins JF. Oral Administration of Ginger-Derived Lipid Nanoparticles and Dmt1 siRNA Potentiates the Effect of Dietary Iron Restriction and Mitigates Pre-Existing Iron Overload in Hamp KO Mice. Nutrients. 2021; 13(5):1686. https://doi.org/10.3390/nu13051686.

  4. An J, Hu YG, Cheng K, Li C, Hou XL, Wang GL, Zhang XS, Liu B, Zhao YD, Zhang MZ. ROS-augmented and tumor-microenvironment responsive biodegradable nanoplatform for enhancing chemo-sonodynamic therapy. Biomaterials. 2020; 234: 119761. https://doi.org/10.1016/j.biomaterials.2020.119761.

  5. Fang B, Guo P, Yang M, Ma Y, Yan X, Jia Z, Gao W, Ahmad S, Xu C, Liu C, Zhang MZ. A novel fluorescent enhancing platform based on DNA-scaffolded silver nanoclusters for potential inflammatory bowel disease-associated microRNA detection. Talanta. 2020; 218: 121122. https://doi.org/10.1016/j.talanta.2020.121122.

  6. Yang M, Zhang Y, Ma Y, Yan X, Gong L, Zhang M, Zhang, B. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects, Journal of Bio-X Research. 2020; 3(4): 157-173. doi: 10.1097/JBR.0000000000000078

  7. Zhang MZ, Yang CH, Yan XJ, Sung JK, Garg P and Merlin D. Highly Biocompatible Functionalized Layer-by-Layer Ginger Lipid Nano Vectors Targeting P-Selectin for Delivery of Doxorubicin to Treat Colon Cancer. Advanced Therapeutics. 2019; 2: 1900129. https://doi.org/10.1002/adtp.201900129.

  8. Yang M, Zhang F, Yang C, Wang L, Sung J, Garg P, Zhang MZ and Merlin, D. Oral targeted delivery by nanoparticles enhances efficacy of an Hsp90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated cancer. Journal of Crohn's and Colitis. 2020; 14(1):130-141. https://doi.org/10.1093/ecco-jcc/jjz113.

  9. Zhang MZ, Xu CL, Wen LQ, Han MK, Xiao B, Zhou J and Merlin D. A hyaluronidase responsive nanoparticle-based drug delivery system for targeting colon cancer cells. Cancer Research. 2016; 76(24), 7208-7218. DOI: 10.1158/0008-5472.CAN-16-1681

  10. Zhang MZ, Viennois E, Prasad M, Zhang YC, Wang LX, Zhang Z and Merlin D. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016; 101:321-340. doi: 10.1016/j.biomaterials.2016.06.018.